Both in Surgical Instruments
Microbot Medical vs Daxor
Over the past year MBOT returned −43.6% and DXR returned −34.0%; their daily moves had a correlation of -0.02.
MBOT −43.6% DXR −34.0%Growth of $1, one year, split-adjusted
| Metric | MBOT | DXR |
|---|---|---|
| Price | $1.14 | $8.91 |
| Market cap | $76.6M | $52.0M |
| Today | +4.59% | +2.44% |
| 1 month | +6.5% | −13.5% |
| 6 months | −47.9% | −12.1% |
| Year to date | −43.0% | −39.6% |
| 1 year | −46.2% | — |
| Revenue growth (YoY) | — | +2.3% |
| Gross margin | −266.8% | 52.2% |
| Net margin | −2334.9% | −403.2% |
| P/E (TTM) | — | — |
| Price / sales | 221.3× | — |
| Net cash | $67.4M | $18.7M |
| Dividend yield | — | — |
| Volatility (60d) | 51.7% | 43.0% |
| Short % of float | 9.2% | 0.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).